You are here

Article Text

Article menu
Download PDFPDF
Therapeutics/Prevention
Systematic review with meta analysis
Percutaneous vertebroplasty does not reduce pain and disability from osteoporotic vertebral compression fracture
  1. Bronek Boszczyk
  1. Nottingham University Hospitals, Nottingham, UK
  1. Correspondence to : Dr Bronek Boszczyk, Nottingham University Hospitals, Nottingham NG7 2UH, UK; bronek.boszczyk{at}nuh.nhs.uk

https://doi.org/10.1136/ebmed-2015-110233

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Commentary on: Buchbinder R, Golmohammadi K, Johnston RV, et al. Percutaneous vertebroplasty for osteoporotic vertebral compression fracture. Cochrane Database Syst Rev 2015;4:CD006349.OpenUrlPubMed

    Context

    Vertebroplasty is a frequently performed procedure stabilising predominantly osteoporotic vertebral fractures through injection of polymethylmethacrylate (PMMA). Recent placebo-controlled (sham) investigations have assessed the efficacy of vertebroplasty. This Cochrane review provides information about the available randomised controlled trials (RCTs) current to November 2014 and is intended for use in clinical and policy decision-making.

    Methods

    RCTs on adult osteoporotic vertebral fractures published as full articles were considered for inclusion. Comparators were: placebo/sham; supportive care; balloon kyphoplasty or similar procedure; pharmacological treatment; or other form of intervention. Outcome data on pain, disability, quality …

    View Full Text

    Footnotes

    • Competing interests None declared.

    • Provenance and peer review Commissioned; internally peer reviewed.